Observational Study to Assess Safety and Utility Pattern of Topical Steroids
NCT ID: NCT02377557
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1175 participants
OBSERVATIONAL
2015-02-28
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis
NCT06400056
Topical Antifungal Treatment for Tinea Pedis
NCT01396785
Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
NCT02550496
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT07065773
Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
NCT00686855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* In addition to spontaneous adverse event reports, patients will be asked on occurrence of adverse events upon use of topical steroids at 1 month, 2 month, and 6 month after study enrollment by e-mail or phone call
* Causality of adverse events will be assessed by independent two professionals
* Document the utility pattern of topical steroid, misuse (inappropriate indication) or overuse (in terms of application frequency or treatment duration)
* Collection of information related with adverse event management
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical Steroids
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent to participate
* Willing to follow and abide by the protocol
Exclusion Criteria
19 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korean Ministry of Food and Drug Safety
UNKNOWN
College of Pharmacy, Seoul National University
UNKNOWN
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ju-Yeun Lee
Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ju-Yeun Lee, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
College of Pharmacy, Hanyang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
College of Pharmacy, Hanyang University
Gyeonggi-do, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MFDS2014-20384
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.